Abstract
Respiratory injury in burns occurs as a result of thermal, chemical or systemic inflammatory effects. Inhalation injury occurs in up to 40% of patients admitted to hospital following burns. Three stages in the evolution of inhalation injury are described. The early phase (first 48 hours) is associated with pulmonary edema, acute respiratory distress syndrome, airway obstruction, and carbon monoxide and cyanide toxicity. During the middle phase (days to weeks), pneumonia and venous thromboembolism may develop. Late sequelae (months to years post burn injury), while uncommon, include reactive airways dysfunction syndrome, bronchiolitis obliterans and tracheal stenosis. Specific interventions early in the management of inhalation injury are necessary to prevent worsening the injury and minimizing late sequelae.
Keywords: Acute respiratory distress syndrome (ARDS), burns, inhalation burns, pneumonia, reactive airways dysfunction syndrome (RADS), smoke inhalation injury, Acute respiratory distress syndrome, (ARDS), reactive airways dysfunction syndrome, RADS, pneumothorax, fat embolism, Respiratory failure, dyspnea, stridor, drooling, dysphagia, chest tightness, laryngoscopy, carboxyhemoglobin, EDTA, Bronchodilator therapy, Chest Wall Restriction, hypotension, Pulmonary Edema, Bronchospasm, ETT, HFOV, HFPV, ECMO, Venous Thromboembolism, Sinusitis, Haemophilus influenzae, Streptococcus pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, Vocal Cord Paralysis, Tracheostomy, Inhaled Heparin, Antithrombin, Tracheal Stenosis
Current Respiratory Medicine Reviews
Title: Respiratory Burns: A Clinical Review
Volume: 6 Issue: 4
Author(s): Robert J. Boots, Joel M. Dulhunty, Jennifer Paratz and Jeffrey Lipman
Affiliation:
Keywords: Acute respiratory distress syndrome (ARDS), burns, inhalation burns, pneumonia, reactive airways dysfunction syndrome (RADS), smoke inhalation injury, Acute respiratory distress syndrome, (ARDS), reactive airways dysfunction syndrome, RADS, pneumothorax, fat embolism, Respiratory failure, dyspnea, stridor, drooling, dysphagia, chest tightness, laryngoscopy, carboxyhemoglobin, EDTA, Bronchodilator therapy, Chest Wall Restriction, hypotension, Pulmonary Edema, Bronchospasm, ETT, HFOV, HFPV, ECMO, Venous Thromboembolism, Sinusitis, Haemophilus influenzae, Streptococcus pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, Vocal Cord Paralysis, Tracheostomy, Inhaled Heparin, Antithrombin, Tracheal Stenosis
Abstract: Respiratory injury in burns occurs as a result of thermal, chemical or systemic inflammatory effects. Inhalation injury occurs in up to 40% of patients admitted to hospital following burns. Three stages in the evolution of inhalation injury are described. The early phase (first 48 hours) is associated with pulmonary edema, acute respiratory distress syndrome, airway obstruction, and carbon monoxide and cyanide toxicity. During the middle phase (days to weeks), pneumonia and venous thromboembolism may develop. Late sequelae (months to years post burn injury), while uncommon, include reactive airways dysfunction syndrome, bronchiolitis obliterans and tracheal stenosis. Specific interventions early in the management of inhalation injury are necessary to prevent worsening the injury and minimizing late sequelae.
Export Options
About this article
Cite this article as:
J. Boots Robert, M. Dulhunty Joel, Paratz Jennifer and Lipman Jeffrey, Respiratory Burns: A Clinical Review, Current Respiratory Medicine Reviews 2010; 6 (4) . https://dx.doi.org/10.2174/157339810793563730
DOI https://dx.doi.org/10.2174/157339810793563730 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Chronic obstructive pulmonary disease (COPD) from childhood to adulthood: from the past to the future
Chronic obstructive pulmonary disease (COPD) is one of the three leading causes of death worldwide, with a major prevalence in low- and middle-income countries, resulting in a high social and economic cost. It is a heterogeneous respiratory disease, treatable and preventable, that causes persistent and often progressive airway obstruction in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Drug-induced Anaphylaxis
Current Pharmaceutical Design Clinical Analysis Methods of Voice Disorders
Current Bioinformatics Mechanisms of Fetal and Neonatal Renal Impairment by Pharmacologic Inhibition of Angiotensin
Current Medicinal Chemistry From Physiome to Pathome: A Systems Biology Model of Major Depressive Disorder and the Psycho-Immune-Neuroendocrine Network
Current Psychiatry Reviews Update on the Adverse Effects of Clozapine: Focus on Myocarditis
Current Drug Safety Plant based Coagulants for Point of Use Water Treatment – A Review
Current Environmental Engineering Effects of Obesity on Vascular Potassium Channels
Current Vascular Pharmacology Antiviral Drugs that Target Cellular Proteins May Play Major Roles in Combating HIV Resistance
Current Pharmaceutical Design A2A Adenosine Receptor and its Modulators: Overview on a Druggable GPCR and on Structure-Activity Relationship Analysis and Binding Requirements of Agonists and Antagonists
Current Pharmaceutical Design Postoperative Atrial Fibrillation - What Do We Really Know?
Current Vascular Pharmacology Remdesivir and Hydroxychloroquine: A Compassionate Use in Covid-19
Current Drug Targets Thalidomide in Multiple Myeloma
Current Pharmaceutical Biotechnology Imidazole: An Essential Edifice for the Identification of New Lead Compounds and Drug Development
Mini-Reviews in Medicinal Chemistry Comparison of Intra and Post-operative Sedation Efficacy of Dexmedetomidinemidazolam and Dexmedetomidine-propofol for Major Abdominal Surgery
Current Drug Metabolism Nitric Oxide and Teratogenesis: An Update
Current Pharmaceutical Design Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects
Current Cancer Drug Targets Identification of Bioactive Natural Products by Pharmacophore-Based Virtual Screening
Current Pharmaceutical Design Beyond Rodent Models of Pain: Non-Human Primate Models for Evaluating Novel Analgesic Therapeutics and Elaborating Pain Mechanisms
CNS & Neurological Disorders - Drug Targets Mini Review on Cariprazine: A Promising Antipsychotic Agent
CNS & Neurological Disorders - Drug Targets Sedation in PACU: The Role of Propofol
Current Drug Targets